Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLP.L Regulatory News (PLP)

  • There is currently no data for PLP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

7 Jul 2020 07:00

RNS Number : 1802S
Polypipe Group PLC
07 July 2020
 

 

7 July 2020

 

Polypipe Group plc COVID-19 update

 

Polypipe Group plc ("Polypipe", the "Company" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment, today provides an update following its announcement on 7 May 2020, and ahead of its interim results now due to be announced on 15 September 2020 on the impact of the COVID-19 pandemic and the Group's response to date.

 

Current operations 

 

We continue to prioritise the health, safety and wellbeing of our employees, adhering to government guidelines on social distancing and hygiene in all aspects of our operations. 

The Group has seen an improving trend since our update on 7 May, with June 2020 revenue some 30% below 2019 levels compared to 66% below in April 2020. Our Commercial and Infrastructure Systems segment has remained relatively resilient throughout this period, with many contractors managing to return to operations (albeit at reduced productivity levels) and the Group servicing specific, crisis-related emergency project work for NHS hospitals and care/recovery applications, particularly in our Nuaire ventilation business. Recovery in the Residential Systems segment has been somewhat more subdued, reflecting the shutdown of the new house build market for much of April and May, followed by a more measured return to work. Overall, Group revenue for the six months to June 2020 was approximately 24% lower than the six months to June 2019.

We are encouraged by the Group's performance in May and June compared to April and also by reports of better than expected activity in the housing market after its reopening on 13 May 2020, as well as Government-announced increased levels of investment in infrastructure projects. However, at this stage we remain cautious as to whether this performance will be sustained into the autumn and winter.

We are currently manufacturing at all main sites at varying levels of capacity utilisation, and currently have 25% of our workforce furloughed, compared to 61% at the height of the crisis.

Restructuring

Medium-term economic and industry forecasts show a significant impact from the COVID-19 outbreak on both the wider UK economy and specifically the UK construction industry. Latest forecasts from the Construction Products Association show that residential new build demand in 2021 is likely to be 20% lower than 2019 levels, Housing RMI 15% lower than 2019 levels, and commercial demand 18% lower than 2019 levels, even with recovery in the second half of 2021.

 

In light of this medium-term outlook, we are taking regrettable but necessary steps to adjust our manning levels and cost base to reflect this level of demand. Unfortunately, it means that we are entering a consultation period with our employees to review these steps, which if actioned in full, will lead to the loss of approximately 250 jobs or 8% of the workforce. It is important to note that there is no planned permanent closure of any facility, which leaves the Group well placed to react to any sustained but unexpected increase in customer demand.

 

Balance sheet and liquidity

 

The Group reported net debt of £184 million on 31 March 2020 and subsequently completed an equity raise of £120 million in May 2020. The Group's liquidity includes a £350 million revolving credit facility, enabling the Group to continue to invest in its key strategic growth projects.

 

Summary

 

In response to the challenges created by the COVID-19 crisis, the Group has taken significant actions to protect the Group's resilience. Whilst there is inevitable uncertainty in the near term, the Board remains confident it is taking the necessary actions to continue to deliver long-term sustainable returns in markets that remain fundamentally attractive. With this current level of uncertainty, we are not yet reinstating financial guidance, and this remains under review by the Board for the time being.

 

 

Enquiries:

 

Polypipe +44 (0) 1709 772204

Martin Payne, Chief Executive Officer

Paul James, Chief Financial Officer

 

Brunswick +44 (0) 20 7404 5959

Nina Coad / Dan Roberts

 

Notes to Editors:

Polypipe Group plc ("Polypipe", the "Company" or the "Group"), a leading provider of sustainable water and climate management solutions for the built environment is the largest manufacturer in the UK, and among the ten largest manufacturers in Europe, of plastic piping systems for the residential, commercial, civils and infrastructure sectors by revenue. It is also a leading designer and manufacturer of energy efficient ventilation systems in the UK.

The Group operates from 19 facilities in total, and with over 20,000 product lines, manufactures the UK's widest range of plastic piping systems for heating, plumbing, drainage and ventilation. The Group primarily targets the UK and European building and construction markets with a presence in Italy, the Netherlands, Ireland and the Middle East and sales to specific niches in the rest of the world.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKABPABKDKOK
Date   Source Headline
7th May 20202:36 pmRNSResults of Placing
7th May 20207:01 amRNSProposed placing of new ordinary shares
7th May 20207:00 amRNSCOVID-19 Update
1st May 20204:40 pmRNSBlock listing Interim Review
7th Apr 202012:10 pmRNSNotice of AGM
25th Mar 20202:40 pmRNSCOVID 19 update
17th Mar 20207:00 amRNSFinal Results
16th Mar 202011:41 amRNSHolding(s) in Company
4th Feb 202010:26 amRNSDirector Declaration
31st Dec 201911:00 amRNSTotal Voting Rights
6th Dec 20191:17 pmRNSDirector/PDMR Shareholding
25th Nov 20193:24 pmRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSTrading Update
7th Nov 20199:30 amRNSHolding(s) in Company
31st Oct 201910:09 amRNSBlock Listing Application
22nd Oct 20192:51 pmRNSDirector Declaration
1st Oct 20197:00 amRNSAcquisition of Alderburgh group of companies
24th Sep 20194:22 pmRNSHolding(s) in Company
18th Sep 20194:18 pmRNSDirector/PDMR Shareholding
16th Sep 20194:12 pmRNSDirectorate Change
2nd Sep 20192:34 pmRNSTotal Voting Rights
16th Aug 201910:01 amRNSDirector Declaration
14th Aug 20193:42 pmRNSHolding(s) in Company
13th Aug 20197:00 amRNSHalf-year Report
28th Jun 20194:00 pmRNSTotal Voting Rights
7th Jun 201911:08 amRNSDirector/PDMR Shareholding
31st May 20194:00 pmRNSTotal Voting Rights
23rd May 20191:43 pmRNSResult of AGM
23rd May 20197:00 amRNSTrading Update
30th Apr 20194:53 pmRNSTotal Voting Rights
30th Apr 20193:02 pmRNSDirector/PDMR Shareholding
30th Apr 20192:47 pmRNSDirector/PDMR Shareholding
15th Apr 20194:20 pmRNSAnnual Financial Report
2nd Apr 201912:08 pmEQSEdison Investment Research Limited: Edison issues outlook on Polypipe (PLP)
1st Apr 201911:24 amRNSHolding(s) in Company
19th Mar 20197:00 amRNSFinal Results
28th Feb 20194:15 pmRNSTotal Voting Rights
31st Jan 20194:55 pmRNSTotal Voting Rights
28th Jan 20194:27 pmRNSBoard Committee changes
30th Nov 20184:00 pmRNSTotal Voting Rights
23rd Nov 201812:59 pmRNSHolding(s) in Company
20th Nov 20187:00 amRNSTrading Update
25th Oct 20187:00 amRNSAcquisition of Manthorpe Building Products
5th Oct 20184:11 pmRNSDirector/PDMR Shareholding
17th Sep 201812:20 pmRNSHolding(s) in Company
5th Sep 20189:30 amRNSHolding(s) in Company
3rd Sep 20187:00 amRNSAcquisition of Permavoid Limited
30th Aug 20189:23 amRNSHolding(s) in Company
21st Aug 20182:49 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.